Last reviewed · How we verify
NCT06766617
Assessment of Insulin Sensitivity in Healthy Adults by a 13C-glucose Breath Test : Method Development and Validation
NA trial testing 75 gr Glucose in Insulin Sensitivity/Resistance in 7 participants. Completed in 30 October 2016.
30 October 2016
Quick facts
| Lead sponsor | Société des Produits Nestlé (SPN) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | sequential |
| Masking | none |
| Primary purpose | other |
| Enrollment | 7 |
| Start date | 29 September 2016 |
| Primary completion | 30 October 2016 |
| Estimated completion | 30 October 2016 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- 75 gr Glucose
Conditions studied
- Insulin Sensitivity/Resistance — all drugs for Insulin Sensitivity/Resistance →
Sponsor
Société des Produits Nestlé (SPN) — full company profile →
Who can join
Adults 18 to 40, male only, with Insulin Sensitivity/Resistance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current research project aims to assess the insulin resistance (less sensitivity), from measures of insulin and glucose in response to a standard oral intake of glucose (standardized oral glucose tolerance test). For this, we wish to test and validate the method of glucose labelled 13-C (stable isotope) breath test in comparison with standardized methods to measure glucose and insulin. Comparative methods that will be used are measures of glycemia from venous blood withdrawal and continuous glucose measurement in the skin tissue (external face of the arm) using the Abbott's freestyle libre system. Repeatability and reliability of the 13-C glucose breath test will be checked from repeated measures over time.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06766617
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insulin Sensitivity/Resistance
Currently open trials in the same condition.
- NCT06856291 — Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance · recruiting
- NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting
- NCT06688461 — High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes · NA · recruiting
- NCT06772857 — Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients · EARLY_PHASE1 · active not recruiting
- NCT04055428 — NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals · Phase 2 · recruiting
Other Société des Produits Nestlé (SPN) trials
Trials by the same sponsor.
- NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
- NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06766617 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
- Last refreshed: 9 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06766617.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing